Have a personal or library account? Click to login
Staurosporine induces different cell death forms in cultured rat astrocytes Cover

Staurosporine induces different cell death forms in cultured rat astrocytes

Open Access
|Nov 2012

References

  1. 1. Jiang YG, Peng Y, Koussougbo KS. Necroptosis: a novel therapeutic target for glioblastoma. Med Hypotheses 2011; 76: 350-2.10.1016/j.mehy.2010.10.037
  2. 2. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Cell Mol Biol 2008; 9: 231-41.10.1038/nrm2312
  3. 3. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2009; 16: 3-11.10.1038/cdd.2008.150
  4. 4. Kumar S. Caspase function in programmed cell death. Cell Death Differ 2007; 14: 32-43.10.1038/sj.cdd.4402060
  5. 5. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 2: 112-9.10.1038/nchembio711
  6. 6. Holle, N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 6: 489-95.10.1038/82732
  7. 7. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation driven assembly of the RIP1 RIP3 complex regulates programmed necrosis and virus induced inflammation. Cell 2009; 137: 1112-23.10.1016/j.cell.2009.05.037
  8. 8. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325: 332-6.10.1126/science.1172308
  9. 9. Rollins S, Perkins E, Mandybur G, Zhang JH. Oxyhemoglobin produces necrosis, not apoptosis in astrocytes. Brain Res 2002; 945: 41-9.10.1016/S0006-8993(02)02562-3
  10. 10. Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol 2004; 72: 111-27.
  11. 11. Laird MD, Wakade C, Alleyne CH, Dhandapani KM. Hemin induced necroptosis involves glutation depetion in mouse astrocytes. Free Radic Biol Med 2008; 45: 1103-14.10.1016/j.freeradbiomed.2008.07.00318706498
  12. 12. Falsig J, Latta M, Leist M. Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. J Neurochem 2004; 1: 181-93.10.1111/j.1471-4159.2004.02144.x
  13. 13. Šimenc J, Lipnik-Štangelj M. Staurosporine induces apoptosis and necroptosis in cultured rat astrocytes. Drug Chem Toxicol 2012; 35: 399-405.10.3109/01480545.2011.633087
  14. 14. Eruslanov E. Kusmartsev S. Identification of ROS using oxidized DCFDA and flow cytometry. In: Armstrong D, editor. Advanced protocols in oxidative stress II, Methods in Molecular Biology. New York: Humana Press; 2010. p. 57-72.10.1007/978-1-60761-411-1_4
  15. 15. Martin SJ, Reutelingsperger CEM, McGahon AJ, Rader JA, van Schie RCAA, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-56.10.1084/jem.182.5.1545
  16. 16. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.10.1016/0022-1759(95)00072-I
  17. 17. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 1994; 170: 145-57.10.1016/0022-1759(94)90390-5
  18. 18. Todorovic V, Sersa G, Mlakar V, Glavac D, Cemazar M. Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin. Radiol Oncol 2012; 46: 32-45.10.2478/v10019-012-0010-6342376022933978
  19. 19. Vranic A. New developments in surgery of malignant gliomas. Radiol Oncol 2011; 45: 159-65.10.2478/v10019-011-0018-3342373622933950
  20. 20. Stepczynska A, Lauber K, Engels IH, Janssen O, Kabelitz D, Wesselborg S, et al. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 2001; 20: 1193-202.10.1038/sj.onc.120422111313863
  21. 21. Belmokhtar CA, Hillion J, Ségal-Bendirdjian E. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 2001; 20: 3354-62.10.1038/sj.onc.120443611423986
  22. 22. Xue LY, Chiu SM, Oleinick NL. Staurosporine-induced death of MCF-7 human breast cancer cells: a distinction between caspase-3 dependent steps of apoptosis and the critical lethal lesions. Exp Cell Res 2003; 283: 135-45.10.1016/S0014-4827(02)00032-0
  23. 23. Zhang XD, Gillespie SK, Hersey P. Staurosporine induces apoptosis of melanoma by both caspase dependent and independent apoptotic pathways. Mol Cancer Ther 2004; 3: 187-97.10.1158/1535-7163.187.3.2
  24. 24. D’Alimonte I, Ballerini P, Nargi E, Buccella S, Giuliani P, Di Iorio P, et al. Staurosporine-induced apoptosis in astrocytes is prevented by A1 adenosine receptor activation. Neurosci Lett 2007; 418: 66-71.10.1016/j.neulet.2007.02.06117400382
  25. 25. Kim SY, Morgan MJ, Choksi S, Liu ZG. TNF induced activation of the Nox 1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 2007; 26: 675-87.10.1016/j.molcel.2007.04.02117560373
  26. 26. Song JH, Bellail A, Tse MCL, Wee Yong V, Hao C. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis inducing ligand induced apoptosis. J Neurosci 2006; 26: 3299-308.10.1523/JNEUROSCI.5572-05.2006667408616554480
  27. 27. Sharon Biton S, Ashkenazi A. NEMO and RIP1 control cell fate in Response to extensive DNA damage via TNF-α feedforward signaling. Cell 2011; 145: 92-103.10.1016/j.cell.2011.02.02321458669
  28. 28. Mao H, Lebrun DG, Yang J, Zhu VF, Li M. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest 2012, 30: 48-56.10.3109/07357907.2011.630050379988422236189
DOI: https://doi.org/10.2478/v10019-012-0036-9 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 312 - 320
Submitted on: Mar 22, 2012
|
Accepted on: May 18, 2012
|
Published on: Nov 9, 2012
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Janez Simenc, Metoda Lipnik-Stangelj, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.